Chiasma Return on Equity

Chiasma (CHMA) currently reports a ROE of -143.47%. That is below the Healthcare sector average of 21.67%. Use the charts on this page to explore Chiasma's ROE history and peer comparisons.

Chiasma's ROE of -143.47% is lower than the Healthcare sector average of 21.67%. That is roughly 762.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Chiasma's current -143.47% should be judged against Healthcare norms (sector average: 21.67%) and against CHMA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -143.47%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Chiasma, and consider following CHMA for alerts when major investors trade the stock.

Chiasma is classified in the Healthcare sector. On ROE, it currently shows -143.47% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CHMA with unrelated industries.